Cargando…
Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models
Mutations in TRPC6 are a cause of autosomal dominant focal segmental glomerulosclerosis in humans. Many of these mutations are known to have a gain-of-function effect on the non-specific cation channel function of TRPC6. In vitro studies have suggested these mutations affect several signaling pathwa...
Autores principales: | Brown, Brittney J., Boekell, Kimber L., Stotter, Brian R., Talbot, Brianna E., Schlondorff, Johannes S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342776/ https://www.ncbi.nlm.nih.gov/pubmed/35913909 http://dx.doi.org/10.1371/journal.pone.0272313 |
Ejemplares similares
-
Trpc6 gain-of-function disease mutation enhances phosphatidylserine exposure in murine platelets
por: Boekell, Kimber L., et al.
Publicado: (2022) -
Mutations in the formin protein INF2 cause focal segmental glomerulosclerosis
por: Brown, Elizabeth J., et al.
Publicado: (2009) -
An inactivating human TRPC6 channel mutation without focal segmental glomerulosclerosis
por: Batool, Lilas, et al.
Publicado: (2023) -
Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis
por: Barua, Moumita, et al.
Publicado: (2013) -
The Treatment of Minimal Change Nephropathy and Focal Segmental Glomerulosclerosis
por: Mason, P D
Publicado: (1997)